Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
<p><b>Background</b></p> The serotonin 4 receptor (5-HT4R) is a promising target for the treatment of depression. Highly selective 5-HT4R agonists, such as prucalopride, have antidepressant-like and procognitive effects in preclinical models, but their clinical effects are no...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Cambridge University Press
2024
|